GAD1 and schizophrenia: Previous studies have reported decreases in the number of inhibitory interneurons, amount of GABA, and expression of the GABA-synthesizing enzyme GAD67 in the cerebral cortex of patients with neuropsychiatric disorders such as schizophrenia, depression, dementia, and multiple sclerosis [50–54].